Complement deficiency, especially deficiencies of the early complement components of the classical pathway, may be associated with systemic lupus erythematosus and other lupuslike diseases.' 2 Genetic deficiency of Cl inhibitor is associated with hereditary angioneurotic oedema, which in some cases has been associated with systemic lupus erythematosus."5 The trait of hereditary angioneurotic oedema is proposed as autosomal dominant. '4 The acquired form of Cl inhibitor deficiency, .first described by Constanzi et al in 1%9,6 is usually associated with B cell lymphoproliferative disorders, such as lymphoma, lymphosarcoma, chronic lymphocytic leukaemia, paraproteinaemia, or macroglobulinaemia.79 As far as we know, no case of acquired Cl inhibitor deficiency associated with systemic lupus erythematosus has been described previously.
Case history A 22 year old unmarried woman was admitted because of fever (390C) in November 1987. Seven years before the admission, at the age of 14, she had received corticosteroid treatment because of fever, facial erythema, and a positive test for antinuclear antibody. She had had no previous episodes of angioedema. On admission she had a malar rash, lymphopenia, a positive test for antinuclear antibody, and an abnormal titre for antibody to DNA. After steroid treatment she convalesced and left the hospital. In April 1988 she was admitted again because of a recurrence of fever and worsening of the laboratory findings for inflammation. After an increased dose of steroid (40 mg/day prednisolone) she left the hospital again. After admission the patient showed manic symptoms. She was diagnosed as having psychosis associated with systemic lupus erythematosus, as her psychotic symptoms appeared together with fever when the erythrocyte sedimentation rate and C reactive protein increased after tapering the steroid treatment. Additionally, the high concentrations of protein, lactate, and pyruvate in the cerebrospinal fluid and diffuse slow waves in the electroencephalogram indicated involvement of the central nervous system.20 21 The patient was treated with pulsed methylprednisolone 1000 mg/day for three days, which markedly improved her psychotic symptoms and the abnormalities in the cerebrospinal fluid and electroencephalogram. After pulse therapy serum concentration of CH50 rose to normal, C3 concentration remained normal, and C4 concentration increased slightly (figure). Clinical course ofthe patient as pulsed methylprednisolone 1000 mglday was given intravenously for three days. Table 1 shows the complement profile of the patient. CH50 was less than 6 units/ml (normal 30-50). Cl was depressed to 11 -0% of functional activity and Clq protein was less than 0-030 g/l (normal 0-087-0:146). C4 activity was 0'0% and C4 protein was less than 001 g/l (normal 0-11-0-46). C2 was 0-8% of functional activity. Functional activities and protein concentrations of C3, C5, C6, C7, C8, C9 were normal except for the raised activity of C9. Cl inhibitor activity was less than 25% and Cl inhibitor protein was less than 0-048 g/l (normal 0 154-0'338). A follow up study showed persistently low levels of functional activities and protein concentrations of Cl inhibitor after pulse therapy.
The possible presence in the patient's serum of antibodies to Cl inhibitor was tested for by determining the recovery of Cl inhibitor activity of the control serum both with and without the addition of the patient's serum. Table 2 shows that the activity of Cl inhibitor in The markedly reduced C4 concentration may play a part in the genesis of profound central nervous system disease in this patient, though the precise mechanism of Cl inhibitor depletion associated with systemic lupus erythematosus remains to be defined.
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